Zacks: Analysts Expect Nu Skin Enterprises, Inc. (NYSE:NUS) Will Announce Earnings of $0.82 Per Share

Equities analysts forecast that Nu Skin Enterprises, Inc. (NYSE:NUSGet Rating) will announce earnings per share of $0.82 for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for Nu Skin Enterprises’ earnings. The highest EPS estimate is $0.85 and the lowest is $0.78. Nu Skin Enterprises posted earnings of $1.15 per share during the same quarter last year, which would indicate a negative year-over-year growth rate of 28.7%. The business is expected to announce its next quarterly earnings report on Monday, January 1st.

On average, analysts expect that Nu Skin Enterprises will report full year earnings of $3.80 per share for the current fiscal year, with EPS estimates ranging from $3.73 to $3.85. For the next fiscal year, analysts forecast that the firm will post earnings of $4.09 per share, with EPS estimates ranging from $4.05 to $4.12. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side research firms that that provide coverage for Nu Skin Enterprises.

Nu Skin Enterprises (NYSE:NUSGet Rating) last announced its earnings results on Wednesday, May 4th. The company reported $0.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.73 by $0.03. Nu Skin Enterprises had a net margin of 5.28% and a return on equity of 22.05%. The business had revenue of $604.90 million for the quarter, compared to analyst estimates of $579.70 million. During the same quarter in the previous year, the firm posted $0.91 earnings per share. Nu Skin Enterprises’s revenue was down 10.7% compared to the same quarter last year.

A number of equities analysts recently issued reports on NUS shares. Jefferies Financial Group boosted their target price on shares of Nu Skin Enterprises from $61.00 to $75.00 in a research report on Thursday, February 17th. Zacks Investment Research raised shares of Nu Skin Enterprises from a “hold” rating to a “strong-buy” rating and set a $57.00 price target on the stock in a report on Tuesday, March 29th. TheStreet lowered shares of Nu Skin Enterprises from a “b” rating to a “c+” rating in a report on Friday, February 18th. DA Davidson boosted their price target on shares of Nu Skin Enterprises from $47.00 to $50.00 and gave the company a “neutral” rating in a report on Thursday, February 17th. Finally, StockNews.com lowered shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating in a report on Friday, May 13th. Three analysts have rated the stock with a hold rating, one has given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $60.60.

In other news, Director Andrew D. Lipman sold 1,000 shares of the company’s stock in a transaction dated Friday, April 22nd. The shares were sold at an average price of $47.72, for a total value of $47,720.00. Following the sale, the director now owns 71,214 shares of the company’s stock, valued at approximately $3,398,332.08. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Ryan S. Napierski sold 25,000 shares of the company’s stock in a transaction dated Friday, February 25th. The stock was sold at an average price of $47.40, for a total transaction of $1,185,000.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 28,000 shares of company stock worth $1,333,390. 2.80% of the stock is owned by insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of NUS. State Street Corp lifted its position in Nu Skin Enterprises by 317.6% during the 1st quarter. State Street Corp now owns 6,520,579 shares of the company’s stock valued at $312,205,000 after purchasing an additional 4,959,089 shares during the period. Millennium Management LLC lifted its position in Nu Skin Enterprises by 1,050.2% during the 4th quarter. Millennium Management LLC now owns 703,938 shares of the company’s stock valued at $35,725,000 after purchasing an additional 642,738 shares during the period. Norges Bank acquired a new position in Nu Skin Enterprises during the 4th quarter valued at about $23,843,000. Cooper Creek Partners Management LLC acquired a new position in Nu Skin Enterprises during the 4th quarter valued at about $23,609,000. Finally, The Manufacturers Life Insurance Company lifted its position in Nu Skin Enterprises by 423.3% during the 4th quarter. The Manufacturers Life Insurance Company now owns 430,185 shares of the company’s stock valued at $21,832,000 after purchasing an additional 347,985 shares during the period. Institutional investors and hedge funds own 93.79% of the company’s stock.

NUS stock traded down $1.72 on Friday, reaching $45.42. 5,157 shares of the company were exchanged, compared to its average volume of 989,149. Nu Skin Enterprises has a 12 month low of $39.40 and a 12 month high of $62.70. The stock’s fifty day moving average price is $46.68 and its 200 day moving average price is $47.92. The firm has a market capitalization of $2.28 billion, a PE ratio of 17.46 and a beta of 1.24. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.72 and a quick ratio of 0.95.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 8th. Stockholders of record on Friday, May 27th will be issued a $0.385 dividend. This represents a $1.54 annualized dividend and a dividend yield of 3.39%. The ex-dividend date is Thursday, May 26th. Nu Skin Enterprises’s payout ratio is 57.04%.

About Nu Skin Enterprises (Get Rating)

Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.

Featured Stories

Get a free copy of the Zacks research report on Nu Skin Enterprises (NUS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.